UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October, 2013.
Commission File Number ________________
Novogen Limited
(Translation of registrants name into English)
16-20 Edgeworth David Ave, Hornsby, NSW 2077, Australia
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F x Form 40-F o |
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Note: Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o
Note: Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrants home country), or under the rules of the home country exchange on which the registrants securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrants security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.
Indicate by check mark if the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934. Yes o No x
If yes is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b)
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Novogen Limited (Registrant)
(Signature) *
Andrew Bursill
Date 16 October 2013
* Print the name and title under the signature of the signing officer.
Wednesday 16 October 2013
Novogen Comments on recent share price rise
Novogen today released the following statement by Dr Graham Kelly, CEO of Novogen Ltd.
The Company is unable to provide an explanation for the 45% rise in its ADR stock overnight on the NASDAQ exchange, other than the observation that is followed an article that appeared yesterday in the US press that speculated on the future of the Company.
That article, in part, speculated on the possibility that the Company was engaged in discussions with another party in relation to its super-enzopyran drug technology.
As was flagged in the 2013 Annual Report released recently, the Company is seeking to establish a structure that will facilitate its goal of delivering personalized chemotherapy on an individual patient basis. The Company currently is working towards establishing such a structure that will be announced when and if it is established. Until then, the Company is not in any position to provide any more details.
Yours sincerely,
Lionel Mateo
Company Secretary
Wednesday 16 October
Elvis Onyura
Senior Adviser, Listings Compliance (Sydney)
ASX Compliance Pty Ltd, 20 Bridge Street
Sydney NSW 2000
Dear Elvis,
Request for Trading Halt for Novogen Limited
In accordance with ASX Listing Rule 17.1, Novogen Limited (the Company) requests an
immediate trading halt in respect of its securities (ASX Code: NRT).
In requesting the trading halt, the Company provides the following information:
The trading halt is requested pending the release of a response to the speculations
published in the media in relation to a partnership with another entity;
Unless otherwise requested by the Company, the Company requests the trading halt
to remain in place until an announcement is made to the market;and
The Company is not aware of any reason why the trading halt should not be granted
or of any other information necessary to inform the market about the trading halt.
Yours sincerely,
Lionel Mateo
Company Secretary
N8<.LV;-BP
M8<.LV;-BP8<.LV;-BP8<.LV;-BP8<.LV;-BP8<.LV;-BP
M8<.LV;-BP8<.LV;-BP8<.LV;-BP8<.LV;-BP8<.LV;-BP
M8<.LV;-BP8<.LV;-BP88,--MA@@PTVV&"##3;88(,--MA@@PTVV&"#
M#?\VV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@
M@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@
M@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@
M@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@
M@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@
M@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PW_-MA@@PTVV&"##3;8
M8(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;8
M8(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;8
M8(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;8
M8(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;8
M8(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;8
M8(,--MA@@PTVV&"##3;88(,-_S;88(,--MA@@PTVV&"##3;88(,--MA@@PTV
MV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTV
MV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV``$&S9LV+!APX8-&S9L
MV+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S9L
MV+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S9L
MV+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S9L
MV+!AP_^LV;-BP8<.LV;-BP8<.LV;-BP8<.LV;-BP8<.LV
M;-BP8<.LV;-BP8<.LV;-BP8<.&[=HU;-BP8<.LV;-BP8<.LV
M;-BP8<.LV;-BP8<.LV;-BP8<.LV;-BP8<.LV;-BP8<.LV
M;-BP8<.88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@
M@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@
M@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV_@PTVV&"##3;8
M8(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;8
M8(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;8
M8(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;8
M8(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;8
M8(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;8
M8(,--MA@@PTVV&"##3;88(,--MA@_X,--MA@@PTVV&"##3;88(,--MA@@PTV
MV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTV
MV&"##3;78(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTV
MV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTV
MV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTV
MV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTV
MV&"##3;88/^##3;88(,--MA@`Q!LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-
M&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-
M&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-
M&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-
M&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-
M&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S;_;-BP8<.&
M#1LV;-BP8<.LV;-BP8<.LV;-BP8<.LV;-BP8<.LVV&"##3;8
M8(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;8
M8(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;8
M8(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;8
M8(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;8
M8(,--MA@@PTVV&"##3;88(,--MA@@PTV_]A@@PTVV&"##3;88(,--MA@@PTV
MV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTV
MV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTV
MV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTV
MV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTV
MV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTV
MV&"##3;88(,--O_88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,-
M-MA@@PTVV&!SS3788(,--MA@`P``V&"##3;88(,--MA@@PTVV&"##3;87',-
M-MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,-
M-MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,-
M-MA@@PU`L&'#A@T;-FS8L&'#A@T;-FS8L&'#A@T;-FS8L&'#A@T;-FS8L&'#
MA@T;-FS8L&'#A@T;-FS8L&'#A@T;-FS8L&'#A@T;-FS8L&'#A@T;-FS_V+!A
MPX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+!A
MPX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+!A
MPX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+!A
MPX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+!A
MPX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV&"##3;88(,--MA@@PTVV&"##3;8
M8(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"#_PTVV&"##3;88(,--MA@@PTV
MV%R##38`8(,--M@`@`TV`&"##0#88`,`-MA@@PTVV`"`#38``(`--MA@@PTV
MV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTV
MV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTV
MV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTV
MV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTV
MV&"##3;88(,--MA@@_\--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,-
M-MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,-
M-MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,-
M-MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,-
M-MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,-
M-MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3;88(/_
M#3;88(,--MA@@PTVV&"##3;88',--@```,`UT5QSS3771'/--=%<Z``"`Z(`#!PYDS*`@8P8.
M&0]P.)B!XP&.!S(JR*@@0\8,'`]DR'"PXL`L`-BP8<.LV;-BP8<."`
M%0````"`#1LV;-BP8;NLV;(&P80/`R@HV`('_L&'#A@T;-FS8L`4"```;
M``"!L&'#A@T;-FS8L%T+!``;-FS86&'#A@T;-FS8L&'#!@``@%8````(=`T`
M``"L`#A@TVV&"##3;88(,-``"P@@T``````""M`(`--MA@@PTVV``0R`H`
M`(`-`%9@@PTVV&"##3;88(,--JQ@@PT```"`32#78(,--@````````!@!3;8
M8(,--MA@`P``*F`#@!4``(`--@`````V`&`#`#8`8(,--MA@@PT`5@```#;8
M8(,--MA@@PTVV%R##0``!((--MBP8@4VV`2"#3;88(,--MA@@PTVV&"##3;8
M8(,--MA@@PTVV&"##3;8_V"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTV
MV&"##3;88(,--MA@@PTVV&"##3;88(,--MA@@PTVV&"##3:)'."`#`[@X$`.
M,CB0@P,Y."##`S+@,`,%,LQ`@0PSX/"`#`[,X,`!%`````!D'."`#`_@((,#
M.3@@PPP4R#`##@_(4($,,^`P@P,XS"`##C/(\``.#C@@PP&S``!`#@?(X$`.
M#LQ`P0P.Y"##`S@XD(,,#N0@@PPS4"!#!3(\($,%#CAP0`X`````-MA@@PTV
MUV"##3;88(,--MBL```V`````#;88(,--MA@@PTVV&!S#3;88%.%%=A@$P@V
MV/]@@PTVV&"##3;8``(`-@`````V5@3""BNLL!+("@``````V#"C;88(,-
M-MA@@PTVV&"##38``&````"L$`@V````````8(,--MA@@PTVV&"##3;88,,*
M-@```````%01""ODL,)*(%9@@PTV``"`32#88(,--MA<@PTVV&"##3;8L`(`
M````````V*Q@12"!!!)((%98`0``V&!S#3;88(,--BM@@PT`@%AAA14K6+&"
M%2M8L8(5*ZQ@Q3788`,``%4``!```+!APX8-&S9LV+!APX8-&S9LV+!960$`
M0"!L`+!APX8-&S9LV+!APX8-&S9LV+!APX8-&S9LV+#_8<.LV;-BP8<.&
M#1LV;-BP8<.LV;-BP8<.LV;-BP8<.LV;-BP8<.LV;-BP7<.&
M[5J.`PYD.)@A@\(,'#)F4)B!XP&.!S(JR)A!888#'#-D.)!Q0!8``+,P8<.LV;-BP8<.LV;-BP8<.NV'`<<.)#A8`:%
M&3@
N7;MV[=JU
M:]>L7;MVS=JU:]>N7;MV[=JU:]>N6;MV[=JU:]>N7;MV[=JU:]>N7;MV[=JU
M:]>N7;MV[=JU:]>N7;MV[=JU:]>N7;MV[=JU:]>N7;MV[=JU:]>N7;MV[=JU
M:]>N7;MV[=JU:]>N7;MV[=JU:]>N7;MV[=JU:]>N7;MV[=JU:]>N7;MVS=JU
M:]>L7;MV[=JU:]>N7;MV[=HU:]>N7;-V[=JU:]>N7;MV[=JU:]>N7;MV[=HU
M:]>N7;MV[=JU:]>N7;MV[=JU:]>N7;MV[=JU:^>NG;MV[=JU:]>N7;MV[=JU
M:]>N7;MV[=JU:]>N7?^[=NW:M6O7KEV[=NW:M6O7KEV[=NW:M6O7KEV[=NW:
MM6O77'/--==<<\TUUUQSS3777'/--==<<\TUUUQSS3777'/--==<<\TUUEQS
MS3767'/--==<<\TUUUQSC3777'/--==<<\TUUUASS3777'/--==<<\TUUUQS
MS3777'/--==<<\XUUUQSS37HG'/--==<<\TUUUASS3777'/--==<8\TUUUQS
MS3777'/--==<<\TUUUQSS3777'/--==<<\TUYUQSS3767'/--==<<\TUUUQS
MS3777'/-->=<<\TUUUASS3777'/--==8<\TUUUQSS3776'/--==<<\TUUUS_
M<\TUUUQSS3777&/--==<<\TUUUQCS3777&/--==<<\TUUUQSS3777&/--==<
M<\TUUUQSS3777'/--==<<\TUUUQSS3777'/--==<<\TYUYQSS3777'/--==<
M<\TUUUQSS3777'/--==<<\TUUUQSS3777'/--==<<\TUUUQCS3777'.--==<
M<\TUUUQSS3777'/--==<<\TUUYQSS3777'/--==<<\TUUUQSS3777'.--==<
M<\TUUUQSS3777'/--==<<\TUUEQSS3777'/.->=<<\TUUUQSS3777'/--==<
M<\TUUUQSS3777'/--==<<\TUUUQSS3G77'/--==<_W/--=9<<\TUUUQSS377
M7'.--==<<\TUUEQSS3777'/--==<<\TUUUQSS3777'/--==<<\TUUUQSS377
M7'/--==<<\TUUUQSS3777'/--==<<\TUUUQSS3777'/--==<<\TUUUQSS376
M7'/--==<<\TUUUQCS3777'/--==<<\TUUEQSS3776'/--==8<\TUYUQSS37G
M7'/--==<<\TUUUQSS34`N7;MVK5KUZY=NV;MVK5KUZY=NW;MVK5KUZY=LW;M
MVKEKUZY=NW;MVK5KUZY=NW;MVK5KUZY=NV;MVK5KUZY=NW;MVK5KUZY=NW;M
MVK5KUZY=NW;MVK5KUZY=N_]V[=JU:]>N7;MV[=JU:]>N7;MV[=JU:]>N6;MV
M[=JU:]>N7;MV[=JU:]>N7;MV[9JU:]>N6;MV[=JU:]>N7;MV[=JU:^>N7;MV
M[=JU:]>N7;MV[=JU:]>NG3-W[=JU:]:N7;MV[=HU:]>N7;MV[=JU:]>N7;MV
M[=JU:]>N7;MV[=JU:]>N7;MV[=JU:]>N7;MV[=JU:]>N7;MV[=JU:]>N7;MV
M[=JU:]>N7;MV[=JU:]>N7;MV[=JU:]>N7;-V[=JU:^>N67/--==8<\TUUUQC
MS3777'/--=>@<\XUUUQCS3777'/--==<<\TUUUQSC3777'/--==<<\TUUUQS
MS37_UUQSS3776'/--==8<\TUUUQSS3777'/--==<<\TUUEQSS3777&/--==<
M